4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009861
CEO and Chairman sold 11,120 shares at $31.56 ($350,947)
- CEO and Chairman acquired 11,120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-13 | Exercise or conversion : show line 1 in the form | +11,120 | $0.33 | $3,670 | 1,889,300 | D |
| 2020-02-13 | Sale : show line 2 in the form | −11,120 | $31.56 | $350,947 | 1,878,180 | D |
| Open-market sales · 11,120 sh · avg $31.56 · $350,947 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-13 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −11,120 | 713,280 | D |
| 2020-02-13 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +300,000 | 300,000 | D |
Loading xslF345X03/doc4.xml…